Phase 3: Begin Medication + Monitoring Once your plan is in place, youll begin weekly injections
Misuse or excessive dosing may cause hypoglycemia, organ growth, or other side effects
Patients with poorly controlled diabetes, cardiovascular risk, obesity-related comorbidities, and those facing access barriers should be prioritized
The medicine is paid for separately at the pharmacy, and the amount depends on the country, the pack size, whether a generic is available and whether your health system covers it
This slowing of the digestive process is a mechanism of action for GLP-1s, helping to regulate blood sugar and support weight loss
If it's cardiovascular risk modification or long-tail safety, semaglutide still wins on data depth, not on potency